Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

By G. Ruiz‐Irastorza, M. Ramos-Casals, P. Brito-Zerón, M. Khamashta. Annals of the Rheumatic Diseases, 2008

928 citations recorded by the source corpus.

Subfields: Ophthalmology, Public Health, Environmental and Occupational Health, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5b0892ca67fb58c27911efc440717cfab726cda9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Rheumatology

1. Kai-Uwe Eckardt
2. B. Kasiske

Citations in the corpus

• KDIGO Clinical Practice Guideline for Glomerulonephritis (2012, background): “K There is low-quality evidence that hydroxychloroquine may protect against the onset of LN, against relapses of LN, ESRD, vascular thrombosis, and that it has a favorable impact on lipid profiles.(674)”
• American College of Rheumatology Guidelines for Screening, Case Definition, Treatment and Management of Lupus Nephritis (2012, background): “In addition, HCQ treatment may reduce the risk of clotting events in SLE [17–20].”